What is BiVACOR?
Founded in 2008, BiVACOR is dedicated to developing innovative medical devices. The company boasts a team of world-class engineers, medical specialists, and business executives focused on advancing its proprietary technology. BiVACOR has cultivated a robust collaborative network, both nationally and internationally, to support its growth and development in the critical field of cardiovascular health.
How much funding has BiVACOR raised?
BiVACOR has raised a total of $22M across 2 funding rounds:
Grant
$3M
Series B
$19M
Grant (2021): $3M with participation from National Heart, Lung, and Blood Institute at the U.S. National Institute of Health
Series B (2021): $19M led by Cormorant Asset Management and OneVentures
Key Investors in BiVACOR
National Heart, Lung, and Blood Institute at the U.S. National Institute of Health
The National Heart, Lung, and Blood Institute (NHLBI) is a U.S. government research institute focused on diseases of the heart, blood vessels, and lungs, and blood resources. Their funding typically supports groundbreaking research and development in these critical health areas.
Cormorant Asset Management
Cormorant Asset Management is a life sciences investment firm that provides financial resources to innovative companies in the biotech and allied sectors, with a focus on fundamental scientific principles.
OneVentures
OneVentures is an investment firm that likely focuses on supporting technology and innovation-driven companies, providing capital to fuel growth and development.
What's next for BiVACOR?
With major enterprise-level backing, BiVACOR is poised for significant expansion and further technological development. The recent capital injection, including Series B financing and grants, will likely fuel advancements in clinical trials, manufacturing scale-up, and market penetration. This strategic investment underscores the confidence in BiVACOR's potential to revolutionize treatment for severe heart conditions, positioning the company for sustained growth and impact in the medical device industry.
See full BiVACOR company page
